Cargando…

Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination

Parental hesitancy poses a serious threat to the success of the COVID-19 childhood vaccination campaign. We investigate whether adults' opinions on childhood vaccination can be influenced via two survey experiments in Italy (n = 3,633 participants) and the UK (n = 3,314 participants). Responden...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiavenna, Chiara, Leone, Laura P., Melegaro, Alessia, Rotesi, Tiziano, Bokemper, Scott E., Paintsil, Elliott E., Malik, Amyn A., Huber, Gregory A., Omer, Saad B., Cucciniello, Maria, Pin, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167374/
https://www.ncbi.nlm.nih.gov/pubmed/37198020
http://dx.doi.org/10.1016/j.vaccine.2023.05.017
_version_ 1785038651571306496
author Chiavenna, Chiara
Leone, Laura P.
Melegaro, Alessia
Rotesi, Tiziano
Bokemper, Scott E.
Paintsil, Elliott E.
Malik, Amyn A.
Huber, Gregory A.
Omer, Saad B.
Cucciniello, Maria
Pin, Paolo
author_facet Chiavenna, Chiara
Leone, Laura P.
Melegaro, Alessia
Rotesi, Tiziano
Bokemper, Scott E.
Paintsil, Elliott E.
Malik, Amyn A.
Huber, Gregory A.
Omer, Saad B.
Cucciniello, Maria
Pin, Paolo
author_sort Chiavenna, Chiara
collection PubMed
description Parental hesitancy poses a serious threat to the success of the COVID-19 childhood vaccination campaign. We investigate whether adults' opinions on childhood vaccination can be influenced via two survey experiments in Italy (n = 3,633 participants) and the UK (n = 3,314 participants). Respondents were randomly assigned to: a “risk treatment” that highlighted the potential risks of COVID-19 to a child, a “herd immunity treatment” that emphasized the community benefits of pediatric vaccination, or a control message. Participants’ probability of supporting COVID-19 childhood vaccination was then assessed on a 0–100 scale. We find that the “risk treatment” reduced the proportion of Italian parents strongly against vaccination by up to 29.6 %, while increasing the proportion of neutral parents by up to 45.0 %. The “herd immunity treatment”, instead, was only effective among non-parents, resulting in a lower proportion of individuals against pediatric vaccination and a higher proportion of individuals in favor (both shifted by around 20 %).
format Online
Article
Text
id pubmed-10167374
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-101673742023-05-09 Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination Chiavenna, Chiara Leone, Laura P. Melegaro, Alessia Rotesi, Tiziano Bokemper, Scott E. Paintsil, Elliott E. Malik, Amyn A. Huber, Gregory A. Omer, Saad B. Cucciniello, Maria Pin, Paolo Vaccine Short Communication Parental hesitancy poses a serious threat to the success of the COVID-19 childhood vaccination campaign. We investigate whether adults' opinions on childhood vaccination can be influenced via two survey experiments in Italy (n = 3,633 participants) and the UK (n = 3,314 participants). Respondents were randomly assigned to: a “risk treatment” that highlighted the potential risks of COVID-19 to a child, a “herd immunity treatment” that emphasized the community benefits of pediatric vaccination, or a control message. Participants’ probability of supporting COVID-19 childhood vaccination was then assessed on a 0–100 scale. We find that the “risk treatment” reduced the proportion of Italian parents strongly against vaccination by up to 29.6 %, while increasing the proportion of neutral parents by up to 45.0 %. The “herd immunity treatment”, instead, was only effective among non-parents, resulting in a lower proportion of individuals against pediatric vaccination and a higher proportion of individuals in favor (both shifted by around 20 %). The Authors. Published by Elsevier Ltd. 2023-06-07 2023-05-09 /pmc/articles/PMC10167374/ /pubmed/37198020 http://dx.doi.org/10.1016/j.vaccine.2023.05.017 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Chiavenna, Chiara
Leone, Laura P.
Melegaro, Alessia
Rotesi, Tiziano
Bokemper, Scott E.
Paintsil, Elliott E.
Malik, Amyn A.
Huber, Gregory A.
Omer, Saad B.
Cucciniello, Maria
Pin, Paolo
Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
title Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
title_full Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
title_fullStr Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
title_full_unstemmed Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
title_short Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
title_sort personal risk or societal benefit? investigating adults’ support for covid-19 childhood vaccination
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167374/
https://www.ncbi.nlm.nih.gov/pubmed/37198020
http://dx.doi.org/10.1016/j.vaccine.2023.05.017
work_keys_str_mv AT chiavennachiara personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT leonelaurap personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT melegaroalessia personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT rotesitiziano personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT bokemperscotte personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT paintsilelliotte personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT malikamyna personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT hubergregorya personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT omersaadb personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT cucciniellomaria personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination
AT pinpaolo personalriskorsocietalbenefitinvestigatingadultssupportforcovid19childhoodvaccination